Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Burning, blisters, pain: More than 40 million people worldwide are infected with the herpes virus every year. The virus can pose a serious threat to newborns and people with weakened immune systems.

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections ...

Getting a herpes diagnosis can feel like a death knell for your sex life. But, as these women can attest to, that’s not the case at all ...

Burning, blisters, pain: More than 40 million people worldwide are infected with the herpes virus every year. The virus can pose a serious threat to newborns and people with weakened immune systems.

HSV-2 and VZV, and is expected to have activity against CMV, HHV-6, and HHV-8 as well. The Company has also developed an anti-HIV drug candidate, NV-HIV-1, that has shown strong efficacy in ...

Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data ...

DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

A recent analyst initiation has brought Assembly Biosciences into focus for investors. JMP Securities commenced coverage of the biopharmaceutical firm with a "Market Outperform" rating, highlighting ...

In Nigeria and across the world, whispers about “catching something” from kissing have been around for years. It’s the kind of worry that can make even a peck feel like a gamble you don't want to take ...

The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of cancer diagnoses, growing awareness, the expanding pipeline ...